<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>癌症传EN:An Army on the March</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">癌症传EN:An Army on the March</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<center>
<a href="/3place/azzen">返回首页</a> <a
href="/3place/azzen/mingju.html">本书名句</a> <a
href="/3place/azzen/memo.html">本书注解</a> <a
href="/3place/azzen/index_rich.html">丰富目录</a> <a
href="/3place/azzen/index_readcal.html">同读日历</a> <a
href="/3place/azzen/index_timeline.html">时间线</a> <a
href="/3place/azzen/index_books.html">引用书籍</a> <a
href="/3place/azzen/index_words.html">使用字频</a>
<div id="wx_pic" style="margin:0 auto;display:none;">
<img src='/img/logo.png'/>
</div>
</center>
<h4 id="an-army-on-the-march">An Army on the March</h4>
<p>162 Now we are an army on the march: “Looking Back: Sidney Farber and
the First Remission of Acute Pediatric Leukemia,” Children’s Hospital
Boston,
http://www.childrenshospital.org/gallery/index.cfm?G=49andandandandpage=1
(accessed November 22, 2009).</p>
<p>162 The next step—the complete cure: Kenneth Endicott, quoted in the
Mary Lasker Papers, “Cancer Wars,” National Library of Medicine.</p>
<p>162 The role of aggressive multiple drug therapy: R. C. Stein et al.,
“Prognosis of Childhood Leukemia,” Pediatrics 43, no. 6 (1969):
1056–58.</p>
<p>162 George Canellos, then a senior fellow at the NCI: George
Canellos, interview with author, March 2008.</p>
<p>163 “A new breed of cancer investigators in the 1960s”: V. T. DeVita
Jr., British Journal of Haematology 122, no. 5 (2003): 718–27.</p>
<p>164 “maniacs doing cancer research”: Ronald Piana, “ONI Sits Down
with Dr. Vincent DeVita,” Oncology News International 17, no. 2
(February 1, 2008),
http://www.consultantlive.com/display/article/10165/1146581?pageNumber=2andandandandverify=0
(accessed November 22, 2009).</p>
<p>164 As expected: See Vincent T. DeVita Jr. and Edward Chu, “A History
of Cancer Chemotherapy,” Cancer Research 21: 8643.</p>
<p>164 The MOPP trial: Vincent T. DeVita Jr. et al., “Combination
Chemotherapy in the Treatment of Advanced Hodgkin’s Disease,” Annals of
Internal Medicine 73, no. 6 (1970): 881–95.</p>
<p>166 A twelve-year-old boy: Bruce Chabner, interview with author, July
2009.</p>
<p>166 “Some of the patients with advanced disease”: Henry Kaplan,
Hodgkin’s Disease (New York: Commonwealth Fund, 1972), 15, 458. Also see
DeVita et al., “Combination Chemotherapy in the Treatment.”</p>
<p>167 “no track record, uncertain finances, an unfinished building”:
Joseph V. Simone, “A History of St. Jude Children’s Research Hospital,”
British Journal of Haematology 120 (2003): 549–55.</p>
<p>168 “an all-out combat”: R. J. Aur and D. Pinkel, “Total Therapy of
Acute Lymphocytic Leukemia,” Progress in Clinical Cancer 5 (1973):
155–70.</p>
<p>168 “in maximum tolerated doses”: Joseph Simone et al., “‘Total
Therapy’ Studies of Acute Lymphocytic Leukemia in Children: Current
Results and Prospects for Cure,” Cancer 30, no. 6 (1972): 1488–94.</p>
<p>168 it was impossible to even dose it and monitor it correctly: Aur
and Pinkel, “Total Therapy of Acute Lymphocytic Leukemia.”</p>
<p>168 senior researchers, knowing its risks: “This Week’s Citations
Classic: R. J. A. Aur et al., “Central Nervous System Therapy and
Combination Chemotherapy of Childhood Lymphocytic Leukemia,” Citation
Classics 28 (July 14, 1986).</p>
<p>169 “From the time of his diagnosis”: Jocelyn Demers, Suffer the
Little Children: The Battle against Childhood Cancer (Fountain Valley,
CA: Eden Press, 1986), 17.</p>
<p>170 In July 1968, the St. Jude’s team published: Donald Pinkel et
al., “Nine Years’ Experience with ‘Total Therapy’ of Childhood Acute
Lymphocytic Leukemia,” Pediatrics 50, no. 2 (1972): 246–51.</p>
<p>170 The longest remission was now in its sixth year: S. L. George et
al., “A Reappraisal of the Results of Stopping Therapy in Childhood
Leukemia,” New England Journal of Medicine 300, no. 6 (1979):269–73.</p>
<p>170 In 1979, Pinkel’s team revisited: Donald Pinkel, “Treatment of
Acute Lymphocytic Leukemia” Cancer 23 (1979): 25–33.</p>
<p>170 “ALL in children cannot be considered an incurable disease”:
Pinkel et al, “Nine Years’ Experience with ‘Total Therapy.’”</p>
<h6 id="阅读日期-2026年01月17日-2026年01月17日-共-1-天">阅读日期：
2026年01月17日-2026年01月17日 共： 1 天</h6>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
